PI3K inhibitor provides durable response in metastatic metaplastic carcinoma of the breast: A hidden gem in the BELLE-4 study. [electronic resource]
Producer: 20200213Description: 1333-1338 p. digitalISSN:- 0929-6646
- Aged, 80 and over
- Aminopyridines -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Carcinoma -- drug therapy
- Female
- Humans
- Metaplasia -- pathology
- Morpholines -- administration & dosage
- Paclitaxel -- administration & dosage
- Phosphoinositide-3 Kinase Inhibitors -- therapeutic use
- Randomized Controlled Trials as Topic
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.